Advanced Search

Pediatric Skin Diseases (inc. Genetic Diseases) Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

Section Topics

  • » Autoimmune disorders
  • » Factitial disorders, child abuse
  • » Genetic disorders
  • » Hair & nail disorders
  • » Infectious disorders
  • » Inflammatory disorders
  • » Neonatal dermatology
  • » Pediatric surgery & anesthetics
  • » Tumors
  • » Vascular disorders

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

6
Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.

Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, ..., Fischer G, Powell J, Cohen B, Ben Amitai D. Pediatr Dermatol. 2011 Mar-Apr; 28(2):94-8

1 Evaluation, most recent by

M Ramam and Chander Grover, All India Institute of Medical Sciences, India. F1000 Dermatology

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.